Last update 10 Apr 2026

UTAA-07

Overview

Basic Info

Drug Type
γ-δT, Universal CAR-T
Synonyms
UTAA 07, UTAA07
Target
CD7
Action
inhibitors
Mechanism
CD7 inhibitors(T-cell antigen CD7 inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
CD7 positive Hematologic Neoplasms
Inactive Indication
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Originator Organization
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Active Organization
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with UTAA-07
NCT07338604
/ RecruitingEarly Phase 1
Clinical Study of UTAA07 Injection in the Treatment of CD7 Positive Adult Relapsed/Refractory Hematologic and Lymphatic Systemic Malignancies
100 Clinical Results associated with UTAA-07
Login to view more data
100 Translational Medicine associated with UTAA-07
Login to view more data
100 Patents (Medical) associated with UTAA-07
Login to view more data
100 Deals associated with UTAA-07
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD7 positive Hematologic NeoplasmsPhase 1
China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
12 Dec 2025
T-cell Acute Lymphoblastic Leukemia/LymphomaPreclinical
China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
22 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free